1. Início
  2. Investigação Clínica
  3. Rituximab na terapêutica da nefropatia membranosa

Rituximab na terapêutica da nefropatia membranosa

Dados básicos

Estudos observacionais Nacional Não Financiado Outros Estudo Clínico Académico (Rituximab) Año de incio: 2020

Objectivos do projeto

Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários

Documentos

  • Não há documentos

Participantes

Unidades de investigação

Stakeholders - Promotores

FMUP

Outputs do ensaio clínico

The gut microbiome in chronic kidney disease

Merino-Ribas A.; (...); Sampaio-Maia B.

Book Chapter. 10.1016/B978-0-323-91313-3.00012-X. 2022


Blood, Gut, and Oral Microbiome in Kidney Transplant Recipients

Sampaio, S; (...); Sampaio Maia, B.

Article. 10.4103/ijn.ijn_168_22. 2023

  • Open Access.

Circulating Renalase as Predictor of Renal and Cardiovascular Outcomes in Pre-Dialysis CKD Patients: A 5-Year Prospective Cohort Study

Cerqueira, A; (...); Pestana Vasconcelos, M.

Article. 10.3390/life11030210. 2021

  • Open Access.

Clearing the clouds: Case-report and review of the literature

Relvas, M; (...); Pestana Vasconcelos, M.

Review. 10.1111/sdi.12931. 2021


CLINICAL PREDICTORS OF COVID-19 DISEASE SEVERITY IN KIDNEY TRANSPLANT RECIPIENTS

Gonçalves, PL; (...); Pestana, M

Meeting Abstract. 2021


COVID-19 SEVERITY INFLUENCES ANTI-SARS-COV2 ANTIBODIES TITER IN KIDNEY TRANSPLANT RECIPIENTS

Gonçalves, F; (...); Pestana, M

Meeting Abstract. 2021


Endothelial Dysfunction Is Associated with Cerebrovascular Events in Pre-Dialysis CKD Patients: A Prospective Study

Cerqueira, A; (...); Pestana Vasconcelos, M.

Article. 10.3390/life11020128. 2021

  • Open Access.

Gut Microbiome and Organ Fibrosis

Costa, CFFA; (...); Alencastre, IS

Article. 10.3390/nu14020352. 2022

  • Open Access.

HERPES SIMPLEX VIRUS-2 HEPATITIS FOLLOWING KIDNEY TRANSPLANT: TAKE A SECOND LOOK

Fernandes, S; (...); Pestana, M

Meeting Abstract. 2021


Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement

Oliveira-Silva, C; (...); Tavares, I

Article. 10.1159/000525675. 2023


POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): IS THE SECRET HIDDEN IN THE SPLEEN?

Rodrigues, A; (...); Pestana, M

Meeting Abstract. 2021


Soluble CD59 in peritoneal dialysis: a potential biomarker for peritoneal membrane function

Faria, B; (...); Poppelaars, F

Article. 10.1007/s40620-020-00934-7. 2021

  • Open Access.

Systemic and local complement activation in peritoneal dialysis patients via conceivably distinct pathways

Faria, B; (...); Poppelaars, F

Article. 10.1177/08968608231198984. 2023

  • Open Access.

The urogenital microbiome in chronic kidney disease patients on peritoneal dialysis

Araujoa, R; (...); Sampaio-Maia, B

Article. 10.1016/j.nefro.2023.08.008. 2024

  • Open Access.

UREMIC TOXIN LEVELS ARE ASSOCIATED WITH GUT MICROBIOME CHANGES IN KIDNEY TRANSPLANT RECIPIENTS

Norton, SS; (...); Maia, MBS

Meeting Abstract. 2021


Viral Clearance and Serological Response to SARS-CoV-2 in Kidney Transplant Recipients

Silvano, J; (...); Pestana Vasconcelos, M.

Article. 10.1016/j.transproceed.2020.11.008. 2021

  • Open Access.

Rituximab Na Terapêutica Da Nefropatia Membranosa

Trabalho final de curso

Colaboradores: Manuel Jesus Falcão Pestana Vasconcelos


Rituximab Na Terapêutica Da Nefropatia Membranosa

Dissertação de Mestrado

Colaboradores: Manuel Jesus Falcão Pestana Vasconcelos


Sglt-2 Inhibitors And Nephroprotection: A Systematic Review And Meta-Analysis

Projeto de fim de curso

Colaboradores: Manuel Jesus Falcão Pestana Vasconcelos


Sglt-2 Inhibitors And Nephroprotection: A Systematic Review And Meta-Analysis

Dissertação de Mestrado

Colaboradores: Manuel Jesus Falcão Pestana Vasconcelos


Campos de Estudo

Partilhar